Cargando…
The effect of sibutramine prescribing in routine clinical practice on cardiovascular outcomes: a cohort study in the United Kingdom
BACKGROUND/OBJECTIVES: The marketing authorization for the weight loss drug sibutramine was suspended in 2010 following a major trial that showed increased rates of non-fatal myocardial infarction and cerebrovascular events in patients with pre-existing cardiovascular disease. In routine clinical pr...
Autores principales: | Hayes, J F, Bhaskaran, K, Batterham, R, Smeeth, L, Douglas, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551415/ https://www.ncbi.nlm.nih.gov/pubmed/25971925 http://dx.doi.org/10.1038/ijo.2015.86 |
Ejemplares similares
-
The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort
por: Douglas, Ian J, et al.
Publicado: (2015) -
Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care
por: Douglas, Ian J., et al.
Publicado: (2015) -
Sibutramine on Cardiovascular Outcome
por: Scheen, André J.
Publicado: (2011) -
Cardiovascular Safety Pharmacology of Sibutramine
por: Yun, Jaesuk, et al.
Publicado: (2015) -
Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort
por: Yates, Tom A., et al.
Publicado: (2017)